These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9818475)

  • 1. [Pharmacologic importance of glycation of plasma proteins].
    Beránek M; Palicka V
    Ceska Slov Farm; 1998 Sep; 47(5):211-4. PubMed ID: 9818475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonenzymatic glycation of platelet proteins in diabetic patients.
    Cohen I; Burk DL; Fullerton R; Veis A; Green D
    Semin Thromb Hemost; 1991 Oct; 17(4):426-32. PubMed ID: 1803513
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On glucose transport and non-enzymic glycation of proteins in vivo.
    Hatton MW; Richardson M; Winocour PD
    J Theor Biol; 1993 Apr; 161(4):481-90. PubMed ID: 8412216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation. Part III: application of proteomic analysis to the manufacture of biological drugs.
    Zheng X; Wu SL; Hancock WS
    Int J Pharm; 2006 Sep; 322(1-2):136-45. PubMed ID: 16920285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-enzymatic glycation and protein recognition.
    Bitensky MW; Kowluru A; Kowluru RA
    Prog Clin Biol Res; 1989; 304():185-203. PubMed ID: 2675028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management.
    Rajasekar P; Anuradha CV
    Acta Diabetol; 2007 Jun; 44(2):83-90. PubMed ID: 17530472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of glycation of plasma proteins in diabetes on the binding interaction with polyphenols.
    Xu W; Chen L; Shao R
    Curr Drug Metab; 2014 Jan; 15(1):116-9. PubMed ID: 24479686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
    Actis Dato SM; Rebolledo OR
    Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method to quantify in vivo transferrin glycation: applications in diabetes mellitus.
    Van Campenhout A; Van Campenhout C; Olyslager YS; Van Damme O; Lagrou AR; Manuel-y-Keenoy B
    Clin Chim Acta; 2006 Aug; 370(1-2):115-23. PubMed ID: 16513102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
    Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
    Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis.
    Schmitt S; Linder M; Ständker L; Hammes HP; Preissner KT
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):26-34. PubMed ID: 17926233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased protein glycation in cirrhosis and therapeutic strategies to prevent it.
    Ahmed N; Lüthen R; Häussinger D; Sebeková K; Schinzel R; Voelker W; Heidland A; Thornalley PJ
    Ann N Y Acad Sci; 2005 Jun; 1043():718-24. PubMed ID: 16037298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
    Dawidowicz AL; Kobielski M; Pieniadz J
    Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein glycation: creation of catalytic sites for free radical generation.
    Yim MB; Yim HS; Lee C; Kang SO; Chock PB
    Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.
    Thornalley PJ; Battah S; Ahmed N; Karachalias N; Agalou S; Babaei-Jadidi R; Dawnay A
    Biochem J; 2003 Nov; 375(Pt 3):581-92. PubMed ID: 12885296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-derived modifications of plasma proteins in experimental and human diabetes.
    Januszewski AS; Jenkins AJ; Baynes JW; Thorpe SR
    Ann N Y Acad Sci; 2005 Jun; 1043():404-12. PubMed ID: 16037262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.